Introduction: R Curtis Haltiwanger is a prominent inventor based in West Chester, PA, known for his significant contributions in the field of pharmaceuticals. With a strong foundation in chemistry and a commitment to advancing medical treatments, Haltiwanger has been credited with three notable patents that reflect his inventive spirit and dedication to improving patient care.

Latest Patents: Haltiwanger's recent innovations include two pivotal patents. The first, titled "Forms of a Multicyclic Compound," presents alternative forms of Compound I, detailing processes for their reproducible creation, as well as methods for treating patients utilizing these compounds. The second patent, "Forms of a Fused Pyrrolocarbazole Compound," outlines alternative chemical and solid-state forms of Compound I, also emphasizing reliable production processes and therapeutic applications.

Career Highlights: Currently, Haltiwanger is associated with Cephalon, Inc., a leading biopharmaceutical company dedicated to discovering and developing innovative medicines. His work at Cephalon has been instrumental in advancing various pharmaceutical applications, significantly contributing to the field of medicinal chemistry.

Collaborations: Throughout his career, Haltiwanger has collaborated with esteemed colleagues, including Laurent D Courvoisier and Robert E McKean. These collaborations have enabled the cross-pollination of ideas, fostering a dynamic environment for innovative research and development in their projects.

Conclusion: R Curtis Haltiwanger's inventions stand as a testament to his skills and dedication to improving healthcare. With a focus on pharmaceuticals and patient treatment, his work continues to influence the industry positively. His collaborations and innovations are crucial for driving future advancements in medicine, making him a key figure in the realm of inventors.

Profile summary based on public USPTO records.